Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

C Baumstein
S Block
J Whitworth

Showing results (551-560 of 601) with videos related to

Pageof 61
Sort By:
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|June 23, 2019
First-in-Class, First-in-Human Study Evaluating LV305, a Dendritic-Cell Tropic Lentiviral Vector, in Sarcoma and Other Solid Tumors Expressing NY-ESO-1Neeta Somaiah, Matthew S Block, Joseph W Kim, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|November 24, 2019
Rapid Generation of Sustainable HER2-specific T-cell Immunity in Patients with HER2 Breast Cancer using a Degenerate HLA Class II Epitope VaccineKeith L Knutson, Matthew S Block, Nadine Norton, et al.
European Journal of Cancer (Oxford, England : 1990)|July 23, 2013
Tumour antigen targeted monoclonal antibodies incorporating a novel multimerisation domain significantly enhance antibody dependent cellular cytotoxicity against colon cancerAjay Jain, Bhawna Poonia, Edward C So, et al.
Journal for Immunotherapy of Cancer|August 21, 2020
Therapeutic plasma exchange clears circulating soluble PD-L1 and PD-L1-positive extracellular vesiclesJacob J Orme, Elizabeth Ann L Enninga, Fabrice Lucien-Matteoni, et al.
Frontiers in Immunology|February 14, 2022
Antigen Specific Humoral and Cellular Immunity Following SARS-CoV-2 Vaccination in ANCA-Associated Vasculitis Patients Receiving B-Cell Depleting TherapyPaige K Marty, Virginia P Van Keulen, Courtney L Erskine, et al.
Gynecologic Oncology|April 11, 2024
Phase II trial of pembrolizumab and epacadostat in recurrent clear cell carcinoma of the ovary: An NRG oncology study GY016Lilian T Gien, Danielle M Enserro, Matthew S Block, et al.
ESMO Open|October 28, 2020
Phase II trial of ribociclib and letrozole in patients with relapsed oestrogen receptor-positive ovarian or endometrial cancersGerardo Colon-Otero, Valentina Zanfagnin, Xiaonan Hou, et al.
Plos One|June 10, 2021
Personalized tumor-specific DNA junctions to detect circulating tumor in patients with endometrial cancerTommaso Grassi, Faye R Harris, James B Smadbeck, et al.
Biorxiv : the Preprint Server for Biology|April 16, 2025
Superinfection with intact HIV-1 results in conditional replication of defective proviruses and nonsuppressible viremia in people living with HIV-1Vivek Hariharan, Jennifer A White, Filippo Dragoni, et al.
Nature Microbiology|October 3, 2025
Superinfection promotes replication and diversification of defective HIV-1 proviruses in people with non-suppressible viraemiaVivek Hariharan, Jennifer A White, Filippo Dragoni, et al.
Pageof 61

Showing results (551-560 of 601) with videos related to

Sort By:
Pageof 61
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|June 23, 2019
First-in-Class, First-in-Human Study Evaluating LV305, a Dendritic-Cell Tropic Lentiviral Vector, in Sarcoma and Other Solid Tumors Expressing NY-ESO-1Neeta Somaiah, Matthew S Block, Joseph W Kim, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|November 24, 2019
Rapid Generation of Sustainable HER2-specific T-cell Immunity in Patients with HER2 Breast Cancer using a Degenerate HLA Class II Epitope VaccineKeith L Knutson, Matthew S Block, Nadine Norton, et al.
European Journal of Cancer (Oxford, England : 1990)|July 23, 2013
Tumour antigen targeted monoclonal antibodies incorporating a novel multimerisation domain significantly enhance antibody dependent cellular cytotoxicity against colon cancerAjay Jain, Bhawna Poonia, Edward C So, et al.
Journal for Immunotherapy of Cancer|August 21, 2020
Therapeutic plasma exchange clears circulating soluble PD-L1 and PD-L1-positive extracellular vesiclesJacob J Orme, Elizabeth Ann L Enninga, Fabrice Lucien-Matteoni, et al.
Frontiers in Immunology|February 14, 2022
Antigen Specific Humoral and Cellular Immunity Following SARS-CoV-2 Vaccination in ANCA-Associated Vasculitis Patients Receiving B-Cell Depleting TherapyPaige K Marty, Virginia P Van Keulen, Courtney L Erskine, et al.
Gynecologic Oncology|April 11, 2024
Phase II trial of pembrolizumab and epacadostat in recurrent clear cell carcinoma of the ovary: An NRG oncology study GY016Lilian T Gien, Danielle M Enserro, Matthew S Block, et al.
ESMO Open|October 28, 2020
Phase II trial of ribociclib and letrozole in patients with relapsed oestrogen receptor-positive ovarian or endometrial cancersGerardo Colon-Otero, Valentina Zanfagnin, Xiaonan Hou, et al.
Plos One|June 10, 2021
Personalized tumor-specific DNA junctions to detect circulating tumor in patients with endometrial cancerTommaso Grassi, Faye R Harris, James B Smadbeck, et al.
Biorxiv : the Preprint Server for Biology|April 16, 2025
Superinfection with intact HIV-1 results in conditional replication of defective proviruses and nonsuppressible viremia in people living with HIV-1Vivek Hariharan, Jennifer A White, Filippo Dragoni, et al.
Nature Microbiology|October 3, 2025
Superinfection promotes replication and diversification of defective HIV-1 proviruses in people with non-suppressible viraemiaVivek Hariharan, Jennifer A White, Filippo Dragoni, et al.
Pageof 61